US Senate Confirms Erica Schwartz as New CDC Director Amid Critical Public Health Challenges

The US Senate has finally confirmed Erica Schwartz as the new director of the Centers for Disease Control and Prevention (CDC), a move that has been anticipated for months. Schwartz, a seasoned public health expert with a background in medicine, law, and public health, has a long history of serving the US Public Health Service Commissioned Corps and has spent years advocating for evidence-based policy decisions in public health.

The confirmation hearing was marked by intense scrutiny from both Republican and Democratic senators, who raised concerns about Schwartz's willingness to challenge policy changes dictated by Health and Human Services Secretary Robert F. Kennedy Jr. Several senators were also critical of her initial responses to questions about vaccine policy, which they perceived as being too cautious. However, in the end, Schwartz's extensive credentials and her commitment to the importance of science in public health policy ultimately won over several key votes, including that of Senate committee chair Bill Cassidy (R-LA).

Under normal circumstances, the confirmation of a new CDC director might seem like a routine matter, but these are not normal times. The agency has been grappling with a range of critical public health challenges, including a devastating cyclosporiasis outbreak that has affected nearly 15 states, widespread measles transmission, and an ongoing Ebola outbreak in the Democratic Republic of the Congo. Moreover, the CDC has been beset by layoffs and resignations, which have reduced its workforce by nearly a quarter, and is still reeling from a shooting at its headquarters in Atlanta last year.

According to American Public Health Association CEO Georges Benjamin, the CDC is currently in a state of limbo, desperately in need of stability, experienced leadership, and a steadfast commitment to science. With millions of Americans relying on the agency for accurate guidance on COVID-19 vaccination and other critical public health issues, it is essential that the CDC is led by a director who is not only knowledgeable about public health but is also willing to stand up to those who might seek to undermine the scientific consensus on key policy issues.

Schwarz has said that she will never betray the science and will continue to lead by her integrity, a statement that has been welcomed by many in the public health community. As she takes on this challenging role, she will face difficult decisions on how to address the ongoing public health crises that are affecting communities across the country. By prioritizing evidence-based decision-making and upholding the importance of scientific integrity in public health policy, she has the potential to lead the CDC out of this period of turmoil and back towards its core mission of protecting the nation's health and well-being.

One key area that Schwartz will need to address is the ongoing measles outbreak, which has been spreading rapidly across the country due to vaccine hesitancy and misinformation. According to the CDC, more than 100 cases of measles have been reported in just the past few months, with the majority of cases occurring in communities with low vaccination rates. Schwartz has pledged to support efforts to promote vaccination and combat vaccine misinformation, but this will be a difficult task that will require significant resources and coordination.

Another key challenge for Schwartz will be navigating the increasingly polarized politics of public health. In a Senate confirmation process marked by intense partisanship and ideological divisions, Schwartz faced intense scrutiny over her views on vaccine policy and the role of politics in public health decision-making. However, by emphasizing her commitment to the importance of science and evidence-based policy, she may be able to build bridges across the partisan divide and work towards a more bipartisan approach to public health policy.

The confirmation of Erica Schwartz as CDC director marks an important turning point for the agency and for the nation's public health infrastructure. By prioritizing evidence-based decision-making and upholding the importance of scientific integrity in public health policy, Schwartz has the potential to lead the CDC back towards its core mission of protecting the nation's health and well-being. As she takes on this critical role, she will face many challenges, but with her extensive credentials and commitment to the importance of science, she is well-equipped to tackle the complex public health issues that are affecting communities across the country.

Help make CIDRAP's vital work possible to support the public health infrastructure and ensure that accurate and reliable guidance is provided to those in need.

CIDRAP - Center for Infectious Disease Research & PolicyResearch and Innovation Office, University of Minnesota, Minneapolis, MN

© 2026 Regents of the University of Minnesota. All rights Reserved.The University of Minnesota is an equal opportunity educator and employer

Research and Innovation Office | Contact U of M | Privacy Policy